chemical kindling
Recently Published Documents


TOTAL DOCUMENTS

47
(FIVE YEARS 2)

H-INDEX

14
(FIVE YEARS 0)

2020 ◽  
Vol 346 ◽  
pp. 108916
Author(s):  
Savita Kumari ◽  
Pallavi Sharma ◽  
Arindam Ghosh Mazumder ◽  
Anil Kumar Rana ◽  
Supriya Sharma ◽  
...  


Planta Medica ◽  
2020 ◽  
Vol 86 (18) ◽  
pp. 1353-1362
Author(s):  
Marzieh Abizadeh ◽  
Soomaayeh Heysieattalab ◽  
Negin Saeedi ◽  
Narges Hosseinmardi ◽  
Mahyar Janahmadi ◽  
...  

AbstractThe objective of the current study was to investigate the anti-epileptogenic and anticonvulsant effects of Dorema ammoniacum gum, which is used in Iranian traditional medicine for the treatment of seizures. Animals received pentylenetetrazol (IP, 30 mg/kg/48 h) for inducing seizures. Five different seizure stages were evaluated for 20 min and parameters including maximum seizure stage, the latency to the onset of stage 4, stage 4 duration, and seizure duration were measured. D. ammoniacum (50 and 100 mg/kg) or its vehicle was administered 30 min before or after pentylenetetrazol injection in different groups. In addition, the effective dose of D. ammoniacum (100 mg/kg) on different seizure stages was compared with the common antiseizure drug phenobarbital. In another set of experiments, we investigated the effective dose of D. ammoniacum on fully kindled animals in which an interictal electroencephalogram was recorded by superficial electrodes placed on the skull. The results showed that D. ammoniacum administration, before and after pentylenetetrazol injections, significantly decreased seizure stage, seizure duration, stage 4 duration, and 1/stage 4 latency. The anti-epileptogenic effect of D. ammoniacum was about 50 to 60% of phenobarbital. In addition, D. ammoniacum significantly decreased seizure stage, seizure duration, stage 4 duration, and 1/stage 4 latency when administered to fully kindled animals but had no effect on the power of EEG sub-bands. These results indicate that D. ammoniacum has anti-epileptogenic and anticonvulsant effects in a chemical kindling model of seizures.



2020 ◽  
Vol 104 ◽  
pp. 106897
Author(s):  
Saeed Tahmasebi ◽  
Shahrbanoo Oryan ◽  
Hamid Reza Mohajerani ◽  
Neda Akbari ◽  
Mohammad Reza Palizvan


2020 ◽  
Vol 18 (3) ◽  
pp. 11
Author(s):  
L.V. Kuznetsova ◽  
M.N. Karpova ◽  
N.Yu. Klishina ◽  
M.L. Kukushkin


IBRO Reports ◽  
2019 ◽  
Vol 6 ◽  
pp. S503
Author(s):  
Seyed Raheleh Ahmadian ◽  
Maryam Ghasemi-Kasman ◽  
Mahdi Pouramir


2019 ◽  
Vol 95 ◽  
pp. 43-50 ◽  
Author(s):  
Samaneh Bagheri ◽  
Ahzdar Heydari ◽  
Azam Alinaghipour ◽  
Mahmoud Salami


2019 ◽  
Vol 12 (1) ◽  
pp. 25-40 ◽  
Author(s):  
Omar M. E. Abdel-Salam ◽  
Amany A. Sleem ◽  
Marawan Abd El-Baset Mohamed Sayed ◽  
Eman R. Youness ◽  
Nermeen Shaffie

Anandamide (N-arachidonoylethanolamine) is an endogenous cannabinoid receptor CB1 ligand that exhibits neuroprotective effects in the brain. In this study, the effect of exogenously given anandamide on pentylenetetrazole (PTZ)-induced chemical kindling oxidative stress and brain damage in rats was studied. Rats were intraperitoneally (i.p.) injected with 35 mg/kg PTZ once every 48 hours for 12 times to induce seizures. Anandamide was i.p. given. 30 min prior to PTZ injection at 100 or 200 mg/kg. Injections of PTZ induced significant increase in brain lipid peroxidation (malondialdehyde: MDA), and nitric oxide associated with marked decrease in brain reduced glutathione (GSH). There were also significant decrements in acetylcholinesterase (AChE) concentration, butyrylcholinesterase (BChE) and paraoxonase-1 (PON-1) activities in brain tissue of PTZ injected rats. Meanwhile, there was no significant effect for PTZ on the concentration of brain neutrophil elastase. Anandamide administered at 100 and 200 mg/kg significantly decreased MDA and increased GSH contents and at 200 mg/kg significantly decreased nitric oxide in brain of PTZ-treated rats. The drug also caused significant increments in AChE concentration and PON-1 activity but had no significant effect on BChE or neutrophil elastase in rats treated with PTZ. Anandamide given at the dose of 200mg/kg significantly decreased the mean seizure scores over the study period by 22.3% and the frequency of myoclonic jerks and rearing (stage 3) by 56.7% compared with the vehicle-treated group. Anandamide given at 100 and 200 mg/kg completely inhibited the development of generalized tonic-clonic seizures (stage 5). It is concluded that in the PTZ-induced seizures, the cannabinoid receptor CB1 agonist anandamide decreases brain oxidative stress, neuronal injury, and exerts an antiepileptic activity.



Sign in / Sign up

Export Citation Format

Share Document